157 related articles for article (PubMed ID: 10096172)
21. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
22. Effects of dydrogesterone on the vascular system.
Seeger H; Mueck AO
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
24. The effect of estradiol metabolites and progestogens on the proliferation of human ovarian cancer cells.
Seeger H; Mueck AO
Panminerva Med; 2006 Mar; 48(1):13-7. PubMed ID: 16633327
[TBL] [Abstract][Full Text] [Related]
25. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
26. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
[TBL] [Abstract][Full Text] [Related]
27. Estrogen augments the vasodilatory effects of vascular endothelial growth factor in the uterine circulation of the rat.
Storment JM; Meyer M; Osol G
Am J Obstet Gynecol; 2000 Aug; 183(2):449-53. PubMed ID: 10942485
[TBL] [Abstract][Full Text] [Related]
28. Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries.
Cox MW; Fu W; Chai H; Paladugu R; Lin PH; Lumsden AB; Yao Q; Chen C
J Surg Res; 2005 Mar; 124(1):104-11. PubMed ID: 15734487
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of sex steroids. Future developments.
Kuhl H
Maturitas; 2004 Apr; 47(4):285-91. PubMed ID: 15063481
[TBL] [Abstract][Full Text] [Related]
31. Oestrogens and the heart.
Rosano GM; Panina G
Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
[TBL] [Abstract][Full Text] [Related]
32. Effects of progestogens on thrombosis and atherosclerosis.
Badimon L; Bayés-Genís A
Hum Reprod Update; 1999; 5(3):191-9. PubMed ID: 10438101
[TBL] [Abstract][Full Text] [Related]
33. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits.
Sitruk-Ware R
Menopause; 2002; 9(1):6-15. PubMed ID: 11791081
[TBL] [Abstract][Full Text] [Related]
34. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
35. [Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone].
Mueck AO; Seeger H; Wallwiener D
Zentralbl Gynakol; 2001 Nov; 123(11):648-54. PubMed ID: 11797164
[TBL] [Abstract][Full Text] [Related]
36. Progestogens stimulate prostacyclin production by human endothelial cells.
Hermenegildo C; Oviedo PJ; García-Martínez MC; García-Pérez MA; Tarín JJ; Cano A
Hum Reprod; 2005 Jun; 20(6):1554-61. PubMed ID: 15734756
[TBL] [Abstract][Full Text] [Related]
37. Progestogens and cardiovascular disease. A critical review.
Clarkson TB
J Reprod Med; 1999 Feb; 44(2 Suppl):180-4. PubMed ID: 11392029
[TBL] [Abstract][Full Text] [Related]
38. Progestogen deficiency and endometrial cancer risk.
Schindler AE
Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
[TBL] [Abstract][Full Text] [Related]
39. Estrogen, progestogens and cardiovascular risk.
Stefanick ML
J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
[TBL] [Abstract][Full Text] [Related]
40. The lack of effect of progestogen on bone.
Lindsay R
J Reprod Med; 1999 Feb; 44(2 Suppl):215-20. PubMed ID: 11392035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
